AT-101 (A28 Therapeutics)
N/A
Report date: 2025/05/26 10:52:19
NME
Base Information
Drug NameAT-101 (A28 Therapeutics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesA28 Therapeutics Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A